Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Loss of prostatic acid phosphatase and α-synuclein cause motor circuit degeneration without altering cerebellar patterning.

Rahimi-Balaei M, Buchok M, Vihko P, Parkinson FE, Marzban H.

PLoS One. 2019 Sep 11;14(9):e0222234. doi: 10.1371/journal.pone.0222234. eCollection 2019.

2.

Is There Enhanced Risk of Cerebral Ischemic Stroke by Sulfonylureas in Type 2 Diabetes?

Parkinson FE, Hatch GM.

Diabetes. 2016 Sep;65(9):2479-81. doi: 10.2337/dbi16-0037. No abstract available.

3.

Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.

Zhang D, Xiong W, Jackson MF, Parkinson FE.

J Pharmacol Exp Ther. 2016 Jul;358(1):31-8. doi: 10.1124/jpet.116.232231. Epub 2016 Apr 26.

4.

The Effect of Endogenous Adenosine on Neuronal Activity in Rats: An FDG PET Study.

Parkinson FE, Paul S, Zhang D, Mzengeza S, Ko JH.

J Neuroimaging. 2016 Jul;26(4):403-5. doi: 10.1111/jon.12349. Epub 2016 Apr 15.

5.

Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters.

Wang Y, Zhou Z, Leylek T, Tan H, Sun Y, Parkinson FE, Wang JF.

Neuroscience. 2015 Dec 17;311:374-81. doi: 10.1016/j.neuroscience.2015.10.052. Epub 2015 Nov 2.

PMID:
26541750
6.

Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation.

Chu S, Xiong W, Parkinson FE.

Purinergic Signal. 2014 Dec;10(4):603-9. doi: 10.1007/s11302-014-9421-8. Epub 2014 Aug 17.

7.

Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.

Sun Z, Yathindranath V, Worden M, Thliveris JA, Chu S, Parkinson FE, Hegmann T, Miller DW.

Int J Nanomedicine. 2013;8:961-70. doi: 10.2147/IJN.S39048. Epub 2013 Mar 6.

8.

Regulation of adenosine levels during cerebral ischemia.

Chu S, Xiong W, Zhang D, Soylu H, Sun C, Albensi BC, Parkinson FE.

Acta Pharmacol Sin. 2013 Jan;34(1):60-6. doi: 10.1038/aps.2012.127. Epub 2012 Oct 15. Review.

9.

Metabolic disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and skin administration in rats.

Fediuk DJ, Wang T, Chen Y, Parkinson FE, Namaka MP, Simons KJ, Burczynski FJ, Gu X.

Int J Toxicol. 2012 Sep-Oct;31(5):467-76. doi: 10.1177/1091581812459893.

PMID:
23064701
10.

Inhibition of hippocampal synaptic activity by ATP, hypoxia or oxygen-glucose deprivation does not require CD73.

Zhang D, Xiong W, Chu S, Sun C, Albensi BC, Parkinson FE.

PLoS One. 2012;7(6):e39772. doi: 10.1371/journal.pone.0039772. Epub 2012 Jun 25.

11.

Intracortical injection of endothelin-1 induces cortical infarcts in mice: effect of neuronal expression of an adenosine transporter.

Soylu H, Zhang D, Buist R, Martin M, Albensi BC, Parkinson FE.

Exp Transl Stroke Med. 2012 Mar 12;4(1):4. doi: 10.1186/2040-7378-4-4.

12.

Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders.

Nam HW, McIver SR, Hinton DJ, Thakkar MM, Sari Y, Parkinson FE, Haydon PG, Choi DS.

Alcohol Clin Exp Res. 2012 Jul;36(7):1117-25. doi: 10.1111/j.1530-0277.2011.01722.x. Epub 2012 Feb 6. Review.

13.

Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats.

Fediuk DJ, Wang T, Chen Y, Parkinson FE, Namaka MP, Simons KJ, Burczynski FJ, Gu X.

Biopharm Drug Dispos. 2011 Oct;32(7):369-79. doi: 10.1002/bdd.765. Epub 2011 Aug 2.

PMID:
21812003
14.

Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice.

Kost S, Sun C, Xiong W, Graham K, Cass CE, Young JD, Albensi BC, Parkinson FE.

Behav Brain Res. 2011 Oct 10;224(1):44-9. doi: 10.1016/j.bbr.2011.05.023. Epub 2011 May 27.

PMID:
21645551
15.

Molecular biology of nucleoside transporters and their distributions and functions in the brain.

Parkinson FE, Damaraju VL, Graham K, Yao SY, Baldwin SA, Cass CE, Young JD.

Curr Top Med Chem. 2011;11(8):948-72. Review.

PMID:
21401500
16.

Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.

Zhang D, Xiong W, Albensi BC, Parkinson FE.

J Neurochem. 2011 Jul;118(1):4-11. doi: 10.1111/j.1471-4159.2011.07242.x. Epub 2011 Apr 6.

17.

Tissue deposition of the insect repellent DEET and the sunscreen oxybenzone from repeated topical skin applications in rats.

Fediuk DJ, Wang T, Raizman JE, Parkinson FE, Gu X.

Int J Toxicol. 2010 Dec;29(6):594-603. doi: 10.1177/1091581810380147. Epub 2010 Oct 19.

PMID:
20959613
18.

N-methyl-D-aspartate-evoked adenosine and inosine release from neurons requires extracellular calcium.

Zamzow CR, Bose R, Parkinson FE.

Can J Physiol Pharmacol. 2009 Oct;87(10):850-8. doi: 10.1139/Y09-075.

PMID:
20052011
19.

Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons.

Parkinson FE, Xiong W, Zamzow CR, Chestley T, Mizuno T, Duckworth ML.

J Neurochem. 2009 Apr;109(2):562-72. doi: 10.1111/j.1471-4159.2009.05991.x. Epub 2009 Feb 13.

20.

Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes.

Zamzow CR, Xiong W, Parkinson FE.

J Neurosci Res. 2008 Nov 15;86(15):3447-55. doi: 10.1002/jnr.21789.

PMID:
18627033
21.

Astrocytes affect the profile of purines released from cultured cortical neurons.

Zamzow CR, Xiong W, Parkinson FE.

J Neurosci Res. 2008 Sep;86(12):2641-9. doi: 10.1002/jnr.21718.

PMID:
18478552
22.
23.

The effect of acidosis on adenosine release from cultured rat forebrain neurons.

Zamzow CR, Bose R, Parkinson FE.

Brain Res. 2006 Apr 12;1082(1):23-31. Epub 2006 Mar 3.

PMID:
16516170
24.

Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake.

Sawynok J, Reid AR, Liu XJ, Parkinson FE.

Eur J Pharmacol. 2005 Aug 22;518(2-3):116-22.

PMID:
16156010
25.
26.

Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model.

Krizanac-Bengez L, Mayberg MR, Cunningham E, Hossain M, Ponnampalam S, Parkinson FE, Janigro D.

J Cell Physiol. 2006 Jan;206(1):68-77.

PMID:
15920760
27.

Astrocytes and neurons: different roles in regulating adenosine levels.

Parkinson FE, Xiong W, Zamzow CR.

Neurol Res. 2005 Mar;27(2):153-60.

PMID:
15829178
28.
29.

Use of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.

Parkinson FE, Friesen J, Krizanac-Bengez L, Janigro D.

Brain Res. 2003 Aug 8;980(2):233-41.

PMID:
12867263
30.

Activation of phospholipases A2 and D of a human neuroblastoma cell line (LA-N-2) by N-dodecyl-L-lysine amide (compound 24), a putative G protein activator: characteristics of inhibition by (-)-nicotine.

Garnham BM, Fitzpatrick-Wong S, Schunack W, Nürnberg B, Sorrentino G, Parkinson FE, Kanfer JN, Sitar DS.

Neurochem Res. 2002 Dec;27(12):1613-8.

PMID:
12515313
31.

Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions.

Parkinson FE, Sinclair CJ, Othman T, Haughey NJ, Geiger JD.

Neuropharmacology. 2002 Oct;43(5):836-46.

PMID:
12384169
32.

Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement.

Othman T, Sinclair CJ, Haughey N, Geiger JD, Parkinson FE.

Neurochem Res. 2002 Apr;27(4):289-96.

PMID:
11958530
33.
34.

Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.

Sinclair CJ, Powell AE, Xiong W, LaRivière CG, Baldwin SA, Cass CE, Young JD, Parkinson FE.

Br J Pharmacol. 2001 Nov;134(5):1037-44.

35.

Adenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole.

Sinclair CJ, Krizanac-Bengez L, Stanness KA, Janigro D, Parkinson FE.

Brain Res. 2001 Apr 13;898(1):122-5.

PMID:
11292455
36.

Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.

Sinclair CJ, LaRivière CG, Young JD, Cass CE, Baldwin SA, Parkinson FE.

J Neurochem. 2000 Oct;75(4):1528-38.

37.

Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia.

Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, Geiger JD.

J Neurochem. 2000 Aug;75(2):795-802.

38.

Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation.

Sinclair CJ, Shepel PN, Geiger JD, Parkinson FE.

Biochem Pharmacol. 2000 Mar 1;59(5):477-83.

PMID:
10660114
39.

Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain.

Anderson CM, Xiong W, Geiger JD, Young JD, Cass CE, Baldwin SA, Parkinson FE.

J Neurochem. 1999 Aug;73(2):867-73.

40.

Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain.

Anderson CM, Baldwin SA, Young JD, Cass CE, Parkinson FE.

Brain Res Mol Brain Res. 1999 Jul 5;70(2):293-7.

PMID:
10407178
41.
42.
43.

Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides.

Anderson CM, Parkinson FE.

Trends Pharmacol Sci. 1997 Oct;18(10):387-92. Review.

PMID:
9357323
44.
45.

Nucleoside transporter-mediated uptake and release of [3H]L-adenosine in DDT1 MF-2 smooth muscle cells.

Foga IO, Geiger JD, Parkinson FE.

Eur J Pharmacol. 1996 Dec 30;318(2-3):455-60.

PMID:
9016938
46.

Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain.

Anderson CM, Xiong W, Young JD, Cass CE, Parkinson FE.

Brain Res Mol Brain Res. 1996 Dec;42(2):358-61.

PMID:
9013795
47.

Ability of nitrobenzylthioinosine to cross the blood-brain barrier in rats.

Anderson CM, Sitar DS, Parkinson FE.

Neurosci Lett. 1996 Nov 29;219(3):191-4.

PMID:
8971812
49.

[3H]adenosine transport in DDT1 MF-2 smooth muscle cells: inhibition by metabolites of propentofylline.

Parkinson FE, Mukherjee K, Geiger JD.

Eur J Pharmacol. 1996 Jul 11;308(1):97-102.

PMID:
8836637
50.

Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.

Parkinson FE, Geiger JD.

J Pharmacol Exp Ther. 1996 Jun;277(3):1397-401.

PMID:
8667202

Supplemental Content

Loading ...
Support Center